Exelixis, Inc.

Membership Level
Company Headquarters
210 E Grand Ave San Francisco, CA 94080

Exelixis, Inc., from the Greek word for “evolution,” is a biopharmaceutical company committed to developing and commercializing small molecule therapies with the potential to improve the treatment of cancer.

© 2021 FLASCO | Premium Website Design by The HDG